Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-04-25 to 2023-05-09
Current total value of award: $18727.05
Description: 4560712258!ATEZOLIZMAB 60MG/ML 1S